PlexBio Co., Ltd.(TW:6572)
NT$6.28+0.32 (+5.37%)
TW:6572
PlexBio Co., Ltd. financials statements
NT$6.28
At close:+0.32 (+5.37%)
PlexBio Co., Ltd. (6572) Ratios
PlexBio Co., Ltd. Ratios
TW:6572's free cash flow for Q2 2026 was NT$-41.21M. For the 2026 fiscal year, TW:6572's free cash flow was increased by NT$0.00 and operating cash flow was NT$-41.21M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.57 | 3.18 | 8.78 | 11.84 | 4.74 |
| Quick Ratio | 3.14 | 2.95 | 8.22 | 11.02 | 4.39 |
| Cash Ratio | 1.64 | 1.58 | 5.11 | 6.71 | 2.41 |
| Solvency Ratio | -0.34 | -0.22 | -0.44 | -0.32 | -0.54 |
| Operating Cash Flow Ratio | -0.68 | -0.03 | -0.54 | -1.54 | -0.58 |
| Short-Term Operating Cash Flow Coverage | -9.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 280.76M | NT$ 338.37M | NT$ 386.30M | NT$ 445.22M | NT$ 486.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.03 | 0.02 | 0.03 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.01 | 0.02 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.44 | 1.53 | 1.22 | 1.21 | 1.37 |
| Debt Service Coverage Ratio | -5.79 | -260.32 | -153.16 | -196.95 | -472.61 |
| Interest Coverage Ratio | -247.72 | -484.93 | -243.93 | -400.81 | -598.49 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.09 | 0.06 | 0.11 | 0.06 | 0.09 |
| Net Debt to EBITDA | 3.69 | 6.11 | 6.65 | 9.25 | 3.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.64% | 38.46% | 37.37% | 30.86% | 30.86% |
| EBIT Margin | -51.65% | -48.00% | -34.85% | -27.71% | -105.14% |
| EBITDA Margin | -38.68% | -33.34% | -24.09% | -17.20% | -85.49% |
| Operating Profit Margin | -51.65% | -62.10% | -38.37% | -35.01% | -108.26% |
| Pretax Profit Margin | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
| Net Profit Margin | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
| Continuous Operations Profit Margin | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.16% | 77.50% | 91.24% | 79.38% | 97.28% |
| Return on Assets (ROA) | -13.99% | -10.77% | -11.33% | -9.13% | -17.96% |
| Return on Equity (ROE) | -20.12% | -16.46% | -13.79% | -11.08% | -24.63% |
| Return on Capital Employed (ROCE) | -19.90% | -19.71% | -13.88% | -12.49% | -23.00% |
| Return on Invested Capital (ROIC) | -19.41% | -19.55% | -13.63% | -12.40% | -22.70% |
| Return on Tangible Assets | -14.00% | -10.78% | -11.34% | -9.14% | -17.97% |
| Earnings Yield | -7.75% | -4.81% | -4.03% | -4.25% | -7.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 31.30 | 32.16 | 311.31 | 86.98 | 23.48 |
| Payables Turnover | 28.16 | 7.99 | 42.53 | 47.71 | 26.51 |
| Inventory Turnover | 1.73 | 2.11 | 3.45 | 3.51 | 1.72 |
| Fixed Asset Turnover | 6.04 | 5.32 | 5.48 | 6.82 | 3.11 |
| Asset Turnover | 0.28 | 0.22 | 0.32 | 0.33 | 0.17 |
| Working Capital Turnover Ratio | 0.38 | 0.32 | 0.36 | 0.37 | 0.21 |
| Cash Conversion Cycle | 210.11 | 138.45 | 98.31 | 100.46 | 214.23 |
| Days of Sales Outstanding | 11.66 | 11.35 | 1.17 | 4.20 | 15.54 |
| Days of Inventory Outstanding | 211.41 | 172.77 | 105.72 | 103.92 | 212.45 |
| Days of Payables Outstanding | 12.96 | 45.67 | 8.58 | 7.65 | 13.77 |
| Operating Cycle | 223.07 | 184.12 | 106.89 | 108.11 | 227.99 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.76 | -0.05 | -0.28 | -0.69 | -0.81 |
| Free Cash Flow Per Share | -0.77 | -0.08 | -0.31 | -0.71 | -0.93 |
| Dividend Paid and CapEx Coverage Ratio | -191.54 | -1.41 | -9.54 | -35.44 | -7.27 |
| Capital Expenditure Coverage Ratio | -191.54 | -1.41 | -9.54 | -35.44 | -7.27 |
| Operating Cash Flow Coverage Ratio | -8.27 | -0.89 | -2.70 | -11.87 | -9.21 |
| Operating Cash Flow to Sales Ratio | -0.62 | -0.04 | -0.18 | -0.37 | -0.67 |
| Free Cash Flow Yield | -9.86% | -0.68% | -2.23% | -5.88% | -5.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.97 | -20.93 | -25.00 | -23.63 | -14.09 |
| Price-to-Sales (P/S) Ratio | 6.34 | 10.00 | 8.68 | 6.53 | 14.83 |
| Price-to-Book (P/B) Ratio | 2.60 | 3.42 | 3.42 | 2.61 | 3.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.14 | -148.10 | -44.91 | -17.00 | -19.32 |
| Price-to-Operating Cash Flow Ratio | -10.19 | -253.18 | -49.58 | -17.48 | -21.98 |
| Price-to-Earnings Growth (PEG) Ratio | -7.65 | -3.91 | -2.55 | 0.39 | 1.93 |
| Enterprise Value Multiple | -12.71 | -23.87 | -29.37 | -28.72 | -14.18 |
| Enterprise Value | 624.92M | 1.02B | 1.18B | 944.64M | 1.51B |
| EV to EBITDA | -12.71 | -23.87 | -29.37 | -28.72 | -14.18 |
| EV to Sales | 4.92 | 7.96 | 7.08 | 4.94 | 12.12 |
| EV to Free Cash Flow | -7.86 | -117.92 | -36.61 | -12.86 | -15.78 |
| EV to Operating Cash Flow | -7.90 | -201.58 | -40.42 | -13.22 | -17.96 |
| Tangible Book Value Per Share | 2.99 | 3.61 | 4.09 | 4.62 | 5.16 |
| Shareholders’ Equity Per Share | 3.00 | 3.61 | 4.09 | 4.63 | 5.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.23 | 1.24 | 1.61 | 1.84 | 1.21 |
| Net Income Per Share | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.95 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.41 | 0.54 | 0.38 | 0.38 | 0.91 |
| SG&A to Revenue | 0.42 | 0.46 | 0.38 | 0.28 | 0.48 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.01 | 0.00 | 0.01 |
| Income Quality | 1.27 | 0.08 | 0.50 | 1.34 | 0.64 |
Currency in TWD
